Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - Allergan plc

30th Oct 2015 16:22

RNS Number : 0975E
FIL Limited
30 October 2015
 



FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,TAKEOVER RULES, 2007 (AS AMENDED)

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIESREPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

FMR LLC and/or one or more of its direct or indirect subsidiaries

And

FIL Limited and/or one or more of its direct and indirect subsidiaries

 

Company dealt in

ALLERGAN PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

Ordinary Shares and preferred convertible stock

Date of dealing

29-October-15

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant securitydealt in (Note 3)

 

Long

Short

 

 

Number (%)

Number (%)

(1) Relevant securities

 

17,535,752 4.44%

(2) Derivatives (other than options)

 

(3) Options and agreements to purchase/sell

 

Total

 

17,535,752 4.44%

 

 

(b) Interests and short positions in relevant securities of the company, other than theclass dealt in (Note 3)

 

Class of relevant security:

 

Long

Short

 

 

Number (%)

Number (%)

(1) Relevant securities

 

(2) Derivatives (other than options)

 

(3) Options and agreements to purchase/sell

Total

 

 

3. DEALINGS (Note 4)

 

(a) Purchases and sales

 

Purchase/sale

 

Number of securities

Price per unit

Sale

1,400

311.08 USD/ Share

Sale

10,200

312.2556 USD/ Share

Sale

4,600

309.8385 USD/ Share

Sale

4,600

310.13 USD/ Share

Buy

18,467

317.7755 USD/ Share

Buy

29,275

315.2542 USD/ Share

Buy

19,868

310.3826 USD/ Share

Sale

40,000

310.0345 USD/ Share

Buy

300

310.93 USD/ Share

Sale

1,002

311.887 USD/ Share

Sale

1,400

314.00 USD/ Share

Sale

65,800

310.5854 USD/ Share

Sale

900

304.1586 USD/ Share

Sale

1,000

312.1288 USD/ Share

Sale

200

311.9625 USD/ Share

Buy

300

304.0033 USD/ Share

Buy

9,900

319.9784 USD/ Share

Buy

1,400

314.00 USD/ Share

Sale

300

310.9667 USD/ Share

Buy (preferred convertible stock 2.8345 conversion factor)

5,450

1,048.9319 USD/ Unit

Buy (preferred convertible stock 2.8345 conversion factor)

1,700

1,045.852 USD/ Unit

Buy (preferred convertible stock 2.8345 conversion factor)

1,050

1,032.0066 USD/ Unit

Buy

228

287.23 USD/ Share

Buy

114

287.10 USD/ Share

Buy

3

284.31 USD/ Share

Buy

10

284.58 USD/ Share

Buy

259

287.2275 USD/ Share

Sale

2

284.80 USD/ Share

Sale

6

285.61 USD/ Share

Sale

2

286.68 USD/ Share

Sale

42

287.5233 USD/ Share

Sale

97

287.52 USD/ Share

Sale

49

287.525 USD/ Share

Sale

3

287.535 USD/ Share

Sale

25

287.526 USD/ Share

Sale

4

286.6825 USD/ Share

Sale

2

285.0166 USD/ Share

Sale

6

287.5225 USD/ Share

Sale

16

287.5266 USD/ Share

Sale

6

284.57 USD/ Share

Sale

1

288.76 USD/ Share

Sale

3

285.596 USD/ Share

Sale

36

286.69 USD/ Share

Sale

12

287.524 USD/ Share

Sale

5

287.53 USD/ Share

Sale

4

291.6833 USD/ Share

Sale

2

286.685 USD/ Share

Sale

2

285.605 USD/ Share

Sale

28

285.6125 USD/ Share

Sale

1

287.565 USD/ Share

Sale

1

278.7858 USD/ Share

Sale

10

287.522 USD/ Share

Sale

23

287.31 USD/ Share

Sale

9

284.795 USD/ Share

Sale

1

286.62 USD/ Share

Sale

8

286.684 USD/ Share

Sale

76

287.5285 USD/ Share

Sale

3

287.5325 USD/ Share

Sale

1

264.75 USD/ Share

 

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

 

 

 

 

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

 

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise

price

Type, e.g. American, European etc.

Expiry

date

Option money

paid/received per unit (Note 5)

 

 

(ii) Exercising

 

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction (Note 8)

 

Details

Price per unit (if applicable) (Note 5)

 

 

 

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

Is a Supplemental Form 8 attached? (Note 9) No

 

 

Date of disclosure

30-October-15

Contact name

Sally-Ann Hatton

Telephone number

01737 837148

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISELLFLRITLIVIE

Related Shares:

PFZ.L
FTSE 100 Latest
Value8,680.29
Change47.96